Home Valencia Technologies Corporation

Valencia Technologies Corporation

Interim Efficacy Data from eCoin® Pivotal Trial Reported

Valencia Technologies announced 6-month interim efficacy data from its eCoin Pivotal Clinical Trial. The announcement follows the podium presentation of the interim data at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2020 Annual Meeting on February 28th, 2020.